(Q35880165)

10 August 2017

1 reference

title

Isradipine--another calcium-channel blocker for the treatment of hypertension and angina (English)

1 reference

10 August 2017

L M Lopez

1

1 reference

10 August 2017

T M Santiago

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 1992

1 reference

Annals of Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

26

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

789-799

1 reference

Effects of calcium on vascular smooth muscle contraction

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

An acute dose-response pharmacodynamic evaluation of orally administered isradipine (PN-200-110) in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Differential effects of isradipine and atenolol on peripheral hemodynamics and arterial compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Hemodynamic study of short- and long-term isradipine treatment in patients with chronic ischemic congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Isradipine (PN 200-110) versus hydrochlorothiazide in mild to moderate hypertension. A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Renal and hemodynamic effects of isradipine in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Electrophysiologic effects of the calcium antagonist isradipine, a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Pharmacokinetics of calcium antagonists under development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600610

10.1177/106002809202600610

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference